China Cord Blood Corp Sets New 1-Year High After Analyst Upgrade (CO)
China Cord Blood Corp (NYSE:CO)’s share price hit a new 52-week high during mid-day trading on Friday after Roth Capital raised their price target on the stock to $6.00, Analyst Ratings Network.com reports. The stock traded as high as $5.00 and last traded at $4.99, with a volume of 108,460 shares trading hands. The stock had previously closed at $4.80.
Separately, analysts at Jefferies Group raised their price target on shares of China Cord Blood Corp from $5.50 to $6.00 in a research note on Friday. One equities research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. China Cord Blood Corp currently has a consensus rating of “Buy” and an average price target of $5.95.
The stock’s 50-day moving average is $4.47 and its 200-day moving average is $4.1. The company has a market cap of $365.0 million and a price-to-earnings ratio of 20.43.
China Cord Blood Corp (NYSE:CO) last issued its quarterly earnings data on Wednesday, June 18th. The company reported $0.07 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.07. On average, analysts predict that China Cord Blood Corp will post $0.28 earnings per share for the current fiscal year.
China Cord Blood Corporation (NYSE:CO) is a provider of cord blood storage services in China.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.